Images
La Opinión de Zamora has published an article summarising the days of oncological research organised by the United Association against Cancer Toro and its Alfoz (AUCCTA) and in which Angel R. Nebreda, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) participated. During his talk, Nebreda commented: "We have come a long way but we still have a lot to do.But think about what we have achieved in the last 30 years, we know a lot more about how cancer develops and we have many more diagnostic methods, we know that there are hereditary cancers, that are genetic, and that they can be prevented by removing breasts and ovaries. We know that lung cancer is directly caused by smoking, and we have advanced in therapies. Some of these work very well, although the problem is resistance".
Link to La Opinión de Zamora
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
